We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

11 hedge funds and large institutions have $415K invested in Catheter Precision in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

10% more funds holding

Funds holding: 10 → 11 (+1)

6% more capital invested

Capital invested by funds: $389K → $415K (+$25.2K)

0.01% less ownership

Funds ownership: 0.06% → 0.05% (-0.01%)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$19.8K
2
Citadel Advisors
Citadel Advisors
Florida
+$11.7K
3
TSS
Two Sigma Securities
New York
+$10.3K
4
XT
XTX Topco
Cayman Islands
+$6.1K
5
UBS Group
UBS Group
Switzerland
+$2.13K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$77.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$14.3K
3
Millennium Management
Millennium Management
New York
-$5.45K
4
HI
Harbour Investments
Wisconsin
-$739
5
Wells Fargo
Wells Fargo
California
-$29
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$279K -$77.1K -758 -23%
Baird Financial Group
2
Baird Financial Group
Wisconsin
$58.8K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$21.6K +$19.8K +195 New
Citadel Advisors
4
Citadel Advisors
Florida
$12.7K +$11.7K +115 New
TSS
5
Two Sigma Securities
New York
$11.2K +$10.3K +101 New
BlackRock
6
BlackRock
New York
$10.8K – – –
UBS Group
7
UBS Group
Switzerland
$8.48K +$2.13K +21 +38%
XT
8
XTX Topco
Cayman Islands
$6.68K +$6.1K +60 New
TRCT
9
Tower Research Capital (TRC)
New York
$4.64K +$102 +1 +2%
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$117 – – –
APC
11
Aspire Private Capital
North Carolina
$70 – – –
Bank of America
12
Bank of America
North Carolina
$36 – – –
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$3 – – –
KFI
14
Key Financial Inc
Pennsylvania
$1 – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$14.3K -155 Closed
Millennium Management
16
Millennium Management
New York
– -$5.45K -59 Closed
HI
17
Harbour Investments
Wisconsin
– -$739 -8 Closed
Wells Fargo
18
Wells Fargo
California
– -$29 – –

VTAK Hedge Fund Activity: Q2 2024 in Review

11 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2024, worth a combined $415K — up 6.5% from $389K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VTAK positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $19.8K. The largest seller was Armistice Capital, cutting an estimated $77.1K.

  • 11 institutional investors held Catheter Precision (VTAK) as of Q2 2024, up from 10 in Q1 2024.
  • Funds reported $415K of Catheter Precision stock for Q2 2024, up 6.5% quarter-over-quarter.
  • 4 funds opened new Catheter Precision positions in Q2 2024 and 3 closed out, a net change of +1 holder.
  • The largest Catheter Precision buyer in Q2 2024 was Renaissance Technologies, an estimated $19.8K added.
  • The largest Catheter Precision seller in Q2 2024 was Armistice Capital, an estimated $77.1K sold.

Based on aggregated 13F filings for Q2 2024.